Fagron N.V.
ISIN: BE0003874915 | Ticker: FAGR
Country: Belgium
Fagron is active in 35 countries in EMEA, North America, and Latin America. Fagron has sterile and non-sterile compounding facilities in Europe (the Netherlands, Belgium, and the Czech Republic), Israel, the United States, Colombia, and South Africa, which supply medications to pharmacies, hospitals, and clinics, as well as directly to patients in South Africa and Colombia.
With over 400 pharmacists within Fagron, we are focused on providing a unique range of high-quality products based on scientific data and insights. The Fagron Brands are unique concepts developed by our R&D specialists to provide pharmacies and clients with exclusive pharmaceutical dosage forms and active pharmaceutical ingredients (APIs). We can provide solutions for all steps inside a compounding setting, either equipment, excipients, APIs, packaging, and much more.
1990
Served areaWorldwide
HeadquartersVenecoweg 20A, 9810 Nazareth, Oost-Vlaanderen – Belgium
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 25.03.24 | Padilla Rafael | Board | Buy | EUR 18,820.34 |
| 19.12.23 | AOC Pharma S.à r.l. | Close relation | Buy | EUR 16,500,000.00 |
| 05.12.23 | AOC Pharma S.à r.l. | Close relation | Buy | EUR 3,001,250.00 |
| 20.10.23 | AOC Pharma S.à r.l. | Close relation | Buy | EUR 7,748.65 |
| 19.10.23 | De Jong Cornelia Neeltje | Board | Buy | EUR 38,750.00 |
| 04.08.22 | Padilla Rafael | Board | Buy | EUR 49,945.00 |
| 03.12.21 | De Jong Cornelia Neeltje | Board | Buy | EUR 27,280.00 |
| 02.12.21 | De Jong Cornelia Neeltje | Board | Buy | EUR 33,250.00 |
| 01.12.21 | Van Rietschoten Constantijn | Executive member | Buy | EUR 33,375.00 |
| 30.11.21 | Verlinden Johan | Executive member | Buy | EUR 66,199.70 |
BE0003874915
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.